The European Prospective Investigation into Cancer and Nutrition Cohort (EPIC): a gateway to rare cancer epidemiological research
ESMO Rare Cancers · 2025
DOI: 10.1016/j.esmorc.2025.100014 ↗Kurz gefasst
Fachartikel in der Zeitschrift ESMO Rare Cancers, 2025. Verfasst von L Fernandez-Cuesta und 20 weiteren Autor:innen. Beteiligte Einrichtung: Rare Cancers Genomic Team, Genomic Epidemiology Branch, International Agency for Research on Cancer (IARC-WHO), Lyon, France. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 3.0). Gefördert von: World Health Organization.
Abstract (Originalsprache)
Background
The intrinsic limitations of studying rare cancers poses challenges to undertaking studies with adequate statistical power. Therefore, efforts are needed to exploit available, high-quality resources. The European Prospective Investigation into Cancer and Nutrition (EPIC) is a large-scale longitudinal cohort with great potential for rare cancer research. Materials and methods: We have used the EPIC data, which includes lifestyle, diet, and health information, on ∼520 000 participants recruited across Europe. Rare cancers were identified according to the RARE CAncer REgistry network (RARECAREnet) classification, which includes incidence-based categorization and detailed morphological and site-specific information.
Results
An interactive R Shiny web application was developed to explore EPIC data interactively, available at https://epic-rare-cancers-explorer.opendata.iarc.who.int. Among the EPIC participants, 11 450 incident cases of rare cancers were identified, with data currently available for 8851 of them, encompassing a wide range of cancer sites and morphologies. Sex ratios and incidence rates align with previously reported statistics. The R Shiny web application was designed for preliminary data analysis and hypothesis generation, aiding researchers in assessing the feasibility and potential of epidemiological studies. Taking head and neck cancers as a use case, we confirmed the strong association of these tumors with tobacco and alcohol consumption, proving the suitability of EPIC for identifying risk factors for rare cancers. However, it is important to note that, as with all observational studies, the associations reported in this article do not establish causality.
Conclusion
The development of the EPIC rare cancers database, accompanied by the development of an interactive web application, represents a significant step forward in rare cancer research embedded within a large-scale population-based cohort. It is therefore vital to promote awareness of this resource within the research community.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Rare Cancers Genomic Team, Genomic Epidemiology Branch, International Agency for Research on Cancer (IARC-WHO), Lyon, France.
- Nutrition and Metabolism Branch, International Agency for Research on Cancer (IARC-WHO), Lyon, France.
- Risk Assessment and Early Detection Team, Genomic Epidemiology Branch, International Agency for Research on Cancer (IARC-WHO), Lyon, France.
- Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, UK.
- Department of Research, Cancer Registry of Norway, Norwegian Institute of Public Health, Oslo, Norway.
- Department of Nutrition, Oslo New University College, Oslo, Norway.
Förderung
- World Health Organization
Zitieren
APA
Fernandez-Cuesta, L., Voegele, C., Hemon, B., Alcala, K., Aune, D., Caini, S., Casalone, E., Cross, A. J., Ferrari, P., Girard, N., Katzke, V., van Leeuwaarde, R. S., Matullo, G., Melin, B., Murphy, G., Viallon, V., Walter, T., Gunter, M. J., Trama, A., …, & Foll, M. (2025). The European Prospective Investigation into Cancer and Nutrition Cohort (EPIC): a gateway to rare cancer epidemiological research. ESMO Rare Cancers. https://doi.org/10.1016/j.esmorc.2025.100014
Vancouver
Fernandez-Cuesta L, Voegele C, Hemon B, Alcala K, Aune D, Caini S, et al. The European Prospective Investigation into Cancer and Nutrition Cohort (EPIC): a gateway to rare cancer epidemiological research. ESMO Rare Cancers. 2025. doi:10.1016/j.esmorc.2025.100014
BibTeX
@article{FernandezCuesta2025,
author = {Fernandez-Cuesta, L and Voegele, C and Hemon, B and Alcala, K and Aune, D and Caini, S and Casalone, E and Cross, A J and Ferrari, P and Girard, N and Katzke, V and van Leeuwaarde, R S and Matullo, G and Melin, B and Murphy, G and Viallon, V and Walter, T and Gunter, M J and Trama, A and Alcala, N and Foll, M},
title = {The European Prospective Investigation into Cancer and Nutrition Cohort (EPIC): a gateway to rare cancer epidemiological research},
journal = {ESMO Rare Cancers},
year = {2025},
doi = {10.1016/j.esmorc.2025.100014}
}
EUVIMED